These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 34633487)

  • 1. Bacteriophage as a Novel Therapeutic Weapon for Killing Colistin-Resistant Multi-Drug-Resistant and Extensively Drug-Resistant Gram-Negative Bacteria.
    Mousavi SM; Babakhani S; Moradi L; Karami S; Shahbandeh M; Mirshekar M; Mohebi S; Moghadam MT
    Curr Microbiol; 2021 Dec; 78(12):4023-4036. PubMed ID: 34633487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phage-based therapy against biofilm producers in gram-negative ESKAPE pathogens.
    Ragupathi NKD; Muthuirulandi Sethuvel DP; Gopikrishnan M; Dwarakanathan HT; Murugan D; Biswas I; Bakthavachalam YD; Murugesan M; George Priya Doss C; Monk PN; Karunakaran E; Veeraraghavan B
    Microb Pathog; 2023 May; 178():106064. PubMed ID: 36898591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria
    Zhang Y; Lin Y; Zhang X; Chen L; Xu C; Liu S; Cao J; Zheng X; Jia H; Chen L; Zhou T
    Microbiol Spectr; 2021 Dec; 9(3):e0123121. PubMed ID: 34730415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating colistin drug resistance: The role of high-throughput sequencing and bioinformatics.
    Aruhomukama D; Sserwadda I; Mboowa G
    F1000Res; 2019; 8():150. PubMed ID: 31354944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug-resistant and extensively drug-resistant Gram-negative prosthetic joint infections: Role of surgery and impact of colistin administration.
    Papadopoulos A; Ribera A; Mavrogenis AF; Rodriguez-Pardo D; Bonnet E; Salles MJ; Dolores Del Toro M; Nguyen S; Blanco-García A; Skaliczki G; Soriano A; Benito N; Petersdorf S; Pasticci MB; Tattevin P; Tufan ZK; Chan M; O'Connell N; Pantazis N; Kyprianou A; Pigrau C; Megaloikonomos PD; Senneville E; Ariza J; Papagelopoulos PJ; Giannitsioti E;
    Int J Antimicrob Agents; 2019 Mar; 53(3):294-301. PubMed ID: 30395988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is colistin effective in the treatment of infections caused by multidrug-resistant (MDR) or extremely drug-resistant (XDR) gram-negative microorganisms in children?
    Ozsurekci Y; Aykac K; Cengiz AB; Bayhan C; Sancak B; Karadag Oncel E; Kara A; Ceyhan M
    Diagn Microbiol Infect Dis; 2016 Jun; 85(2):233-8. PubMed ID: 27041107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of Action of Isopropoxy Benzene Guanidine against Multidrug-Resistant Pathogens.
    Li J; Zhang X; Han N; Wan P; Zhao F; Xu T; Peng X; Xiong W; Zeng Z
    Microbiol Spectr; 2023 Feb; 11(1):e0346922. PubMed ID: 36475769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virulence Determinants and Plasmid-Mediated Colistin Resistance
    Tartor YH; Gharieb RMA; Abd El-Aziz NK; El Damaty HM; Enany S; Khalifa E; Attia ASA; Abdellatif SS; Ramadan H
    Front Cell Infect Microbiol; 2021; 11():761417. PubMed ID: 34888259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?
    Blaskovich MAT; Pitt ME; Elliott AG; Cooper MA
    Expert Rev Anti Infect Ther; 2018 Jun; 16(6):485-499. PubMed ID: 29848132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic Activity of Colistin-Containing Combinations against Colistin-Resistant Enterobacteriaceae.
    Brennan-Krohn T; Pironti A; Kirby JE
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30061285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates.
    Jahangiri A; Neshani A; Mirhosseini SA; Ghazvini K; Zare H; Sedighian H
    Microb Pathog; 2021 Jan; 150():104700. PubMed ID: 33346078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bavachin Rejuvenates Sensitivity of Colistin against Colistin-Resistant Gram-Negative Bacteria.
    Li J; Han N; He Z; Dai X; Zhao F; Li Y; Xiong W; Zeng Z
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysin LysMK34 of
    Abdelkader K; Gutiérrez D; Grimon D; Ruas-Madiedo P; Lood C; Lavigne R; Safaan A; Khairalla AS; Gaber Y; Dishisha T; Briers Y
    Appl Environ Microbiol; 2020 Sep; 86(19):. PubMed ID: 32709718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How Phages Overcome the Challenges of Drug Resistant Bacteria in Clinical Infections.
    Taati Moghadam M; Amirmozafari N; Shariati A; Hallajzadeh M; Mirkalantari S; Khoshbayan A; Masjedian Jazi F
    Infect Drug Resist; 2020; 13():45-61. PubMed ID: 32021319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colistin-phage combinations decrease antibiotic resistance in
    Wang X; Loh B; Gordillo Altamirano F; Yu Y; Hua X; Leptihn S
    Emerg Microbes Infect; 2021 Dec; 10(1):2205-2219. PubMed ID: 34736365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
    Doymaz MZ; Karaaslan E
    Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug Repurposing to Fight Colistin and Carbapenem-Resistant Bacteria.
    Peyclit L; Baron SA; Rolain JM
    Front Cell Infect Microbiol; 2019; 9():193. PubMed ID: 31245302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Gram negative resistance to last-line antimicrobial agents fosfomycin, colistin and ceftazidime-avibactam - epidemiology, laboratory detection and treatment implications.
    Sherry N; Howden B
    Expert Rev Anti Infect Ther; 2018 Apr; 16(4):289-306. PubMed ID: 29543500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe infections caused by multidrug-resistant non-fermentative bacilli in southern Poland.
    Chmielarczyk A; Pobiega M; Ziółkowski G; Pomorska-Wesołowska M; Romaniszyn D; Krawczyk L; Wójkowska-Mach J
    Adv Clin Exp Med; 2018 Mar; 27(3):401-407. PubMed ID: 29533544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of combination therapy for the improvement of colistin activity against bacterial biofilm.
    Jalil AT; Alrawe RTA; Al-Saffar MA; Shaghnab ML; Merza MS; Abosaooda M; Latef R
    Braz J Microbiol; 2024 Mar; 55(1):411-427. PubMed ID: 38030866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.